Search Cancer Clinical Trials

The Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
25 results
  • Sarcoma, Cervical Cancer, Lung Cancer, Kidney Cancer, Head and Neck Cancer

19-090          Phase I

A Phase 1, First-in-Human, Open-Label, Dose Escalation and Cohort Expansion Study of MGD019, a Bispecific DART® Protein Binding PD-1 and CTLA-4 in Patients with Unresectable or Metastatic Neoplasms (View details on clinicaltrial.gov)

  • Melanoma, Colorectal Cancer, Merkel Cell Carcinoma, Sarcoma

17-288          Phase I

A Phase 1/1b first-in-human dose escalation and expansion study for the evaluation of safety, pharmacokinetics, pharmacodynamics and anti-tumor activity of SAR439459 administered intravenously as monotherapy and in combination with REGN2810 in adult patients with advanced solid tumors (View details on clinicaltrial.gov)

  • Sarcoma, Thyroid Cancer, Lung Cancer, Head and Neck Cancer

17-481          Phase II

A Phase 1/2 Study of the TRK Inhibitor LOXO-195 in Adult and Pediatric Subjects with Previously Treated NTRK Fusion Cancers (View details on clinicaltrial.gov)

  • Sarcoma, Colorectal Cancer, Brain Tumors, Gallbladder and Bile Duct Cancers

18-638          Phase II

A Phase 1b/2 Study of FT-2102 in Patients with Advanced Solid Tumors and Gliomas with an IDH1 Mutation (View details on clinicaltrial.gov)

  • Sarcoma

16-171          Phase III

A PHASE 2-3, MULTICENTER, RANDOMIZED, DOUBLEBLIND STUDY OF SELINEXOR (KPT-330) VERSUS PLACEBO IN PATIENTS WITH ADVANCED UNRESECTABLE DEDIFFERENTIATED LIPOSARCOMA (DDLS) (View details on clinicaltrial.gov)

  • Sarcoma

16-626          Phase I

A Phase I Trial of CBT-1® in Combination with Doxorubicin in Patients with Locally Advanced or Metastatic, Unresectable Sarcomas Previously to Have Progressed on 150 mg/m2 or less of Doxorubicin (View details on clinicaltrial.gov)

  • Sarcoma

17-365          Phase II

A Phase II Randomized Controlled Trial of Neoadjuvant Pembrolizumab with Radiotherapy and Adjuvant Pembrolizumab in Patients with High-Risk, Localized Soft Tissue Sarcoma of the Extremity (View details on clinicaltrial.gov)

Showing 1 - 10 of 25 results